ArticleJournal of clinical pathways : the foundation of value-based care

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.

Casey Mason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.